Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
12-Mar-2025 | 565 | 579.9 | 553.75 | 576.15 | 20,757 | 33,48,53,179.1 | 1,37,465 |
13-Mar-2025 | 578.95 | 587.95 | 556.6 | 566.7 | 18,248 | 26,94,40,297.35 | 1,05,414 |
17-Mar-2025 | 566.8 | 596 | 563 | 571.65 | 33,054 | 55,98,70,306.15 | 1,79,829 |
18-Mar-2025 | 576 | 635.5 | 574.25 | 621.55 | 46,417 | 94,14,19,015.45 | 5,76,928 |
19-Mar-2025 | 640 | 665 | 610.6 | 622.8 | 78,338 | 1,65,07,53,163.4 | 5,98,931 |
20-Mar-2025 | 633 | 633 | 605.6 | 622 | 29,215 | 53,14,98,858.8 | 2,21,742 |
21-Mar-2025 | 620 | 637 | 616.15 | 627.1 | 23,713 | 43,43,62,462.85 | 1,66,769 |
24-Mar-2025 | 639.15 | 648 | 618 | 628.15 | 33,097 | 58,87,97,397.35 | 2,08,648 |
25-Mar-2025 | 628.5 | 633 | 586.05 | 591.7 | 28,868 | 43,55,63,022.1 | 2,50,572 |
26-Mar-2025 | 580.9 | 595.9 | 549 | 578.1 | 80,480 | 1,47,67,74,611.75 | 7,12,171 |
27-Mar-2025 | 576.25 | 592.7 | 570.05 | 587.4 | 18,089 | 36,73,13,749.55 | 2,31,075 |
28-Mar-2025 | 587.4 | 597.8 | 565 | 570.6 | 18,609 | 27,99,02,148 | 1,60,922 |
01-Apr-2025 | 567.85 | 577.65 | 560 | 563.95 | 12,588 | 19,16,63,459.7 | 1,06,843 |
02-Apr-2025 | 570 | 574 | 553.55 | 561.1 | 13,390 | 18,79,35,660.1 | 1,03,876 |
03-Apr-2025 | 574 | 598.9 | 572.05 | 577.15 | 32,351 | 56,05,73,624.1 | 2,46,234 |
04-Apr-2025 | 576.9 | 576.9 | 523.65 | 531.85 | 51,166 | 73,84,87,283.4 | 4,97,649 |
07-Apr-2025 | 440.3 | 519.95 | 440.3 | 511.55 | 39,413 | 44,42,79,303 | 2,88,483 |
08-Apr-2025 | 535.85 | 535.85 | 515.05 | 522.95 | 15,454 | 20,58,51,740.85 | 1,15,846 |
09-Apr-2025 | 515 | 522.15 | 494.1 | 515.65 | 21,381 | 27,33,23,026.65 | 1,47,435 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
